Using Medication Assisted Treatment to Treat Opioid Use Disorder: Learning from past Experience to Guide Policy

AATODThis report from the American Association for the Treatment of Opioid Dependence addresses some of the issues that impact the development of policies regarding the use of medications in opioid addiction treatment and the prevention of opioid overdose.

The report discusses whether treating opioid addictions should be viewed as a public health intervention, with the use of federally approved medications such as methadone and buprenorphine as the principal component of care and treatment. Other issues addressed include whether resources should be prioritized to treat opioid addictions with medications and additional clinical services, as well as if there should be coordination to organize service delivery through a continuum of service delivery components. This paper provides a historical perspective of the nation’s current policies for delivering medication-assisted treatment, aiming to examine systems and principles of care so that policymakers can develop future policies that offer greater stability, are based on evidence, and reflect best practices.